MedCity, launched in April 2014 by Mayor of London Boris Johnson with the capital’s three academic health science centres, is kicking off 2015 in new offices at the London BioScience Innovation Centre (LBIC)
The move sees MedCity co-located with a broad range of university spin-outs, entrepreneurial start-ups and established UK and international companies, all focused on life sciences innovation and commercialisation.
The Centre is based near King’s Cross within the newly-emerging ‘Knowledge Quarter’, close to leading research and education institutes including University College London, the new Francis Crick Institute and the Wellcome Trust.
Dr Eliot Forster, Executive Chair of MedCity, says:
“LBIC is a great fit for us, particularly because our new neighbours within the Centre are an excellent example of what MedCity has been set up to support and expand – exciting and innovative companies that are turning cutting edge science into transformative and highly commercial therapies, products and services. It’s a terrific base from which to fulfil our fundamental remit, which is to grow a thriving, internationally competitive life sciences cluster in London and the south east – with far-reaching healthcare and economic benefits for the UK as a whole.”
Dr Ken Larkin, Chief Executive of LBIC, says:
“We are delighted to welcome the MedCity team to LBIC – this is a great initiative for London and a fantastic opportunity for us to work closely with MedCity and other stake holders to support and develop this exciting sector further. Our facility located at the campus of the Royal Veterinary College offers a unique central London location and a strong foundation for organisations such as MedCity to connect to our industry both within London and the wider South East.”
Launched in April 2014 to grow a world-leading life sciences cluster in London and the greater south east, MedCity is focused on four main priorities – providing a single front door and concierge service for industry and investors looking to do business in the region; fostering an environment that supports and encourages entrepreneurialism; facilitating and supporting collaboration across all parts of the sector; and raising awareness globally of the region’s rich life sciences ecosystem.
Current focuses include unlocking investment for life sciences companies by raising awareness of opportunities in the sector amongst new and experienced investors. The organisation launched Angels in MedCity in October to create a community of angel investors focused on life sciences and in January 2015 will hold a one day Future of Healthcare Investor Forum with the London Stock Exchange to showcase leading public and private UK life sciences companies.
It has also worked with companies including Merck and Pfizer to help them set up and expand centres in the region.
MedCity was previously based with the Francis Crick Institute at the Wellcome Trust during its set-up phase.